Doctors Join Patients to Protest at Health Care Freedom Tea Parties July 17; Thousands Join in Nation... ( WASHINGTON July 16 -- W...)

Doctors Join Patients to Protest at Health Care Freedom Tea Parties July 17; Thousands Join in Nationwide Event

Date:7/16/2009

WASHINGTON, July 16 /PRNewswire-USNewswire/ -- "We'll quit before we practice government medicine" will be the message of thousands of doctors at Health Care Freedom Tea Parties on July 17.

The Association of American Physicians and Surgeons is joining the Tea Party Patriots to co-sponsor the protests at the local home office of each Congressman and Senator to make it absolutely clear that doctors and patients oppose government run medicine.

Taxpayers will gather simultaneously across the country from Noon to 1:00 PM Eastern / 9:00 to 10:00 AM Pacific.

The "Take Back Medicine" petition will also be circulated for doctors to sign. Thousands have already signed on to this message to the President and Congress, which begins:

"Physicians can no longer allow medical care in this country to be controlled by government and insurance companies.

"Current reform options purport be "cure-alls" for every American. But we know that every patient is different, and just like patients, there is no single big-government solution to change health care in this country. . .."

The petition and physician stories are available at www.TakeBackMedicine.com.

To arrange an interview with a physician in your area, please contact:

Mary@TakeBackMedicine.com

    DATE:  July 17, 2009
    TIME:  12 noon - 1 pm EDT
    PLACE: Congressional district offices across the country

SOURCE Association of American Physicians and Surgeons (AAPS)
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Post Your Comments:

(Date:12/2/2009)...HICAGO, Dec. 2 Results ... the annual meeting of the Radiological Society of...dence of the benefit of annual screening ultrasoun... risk for breast cancer. In addition, the study co...early breast cancer. ,, "We found that annual s...

(Date:12/2/2009)...rgeted breast ultrasound of suspicious areas of th... cost-effective alternative to invasive biopsies f...f two studies presented today at the annual meetin...NA). , "By performing high-quality breast ultras...oidable invasive diagnostic procedures in young wo...

(Date:12/1/2009)..., NEW YORK, Dec. 1 Reportlinker...s available in its catalogue: ,, Global In Vit...15 ,, http://www.reportlinker.com/p0166596/Gl...casts-to-2015.html ,, Global In Vitro Diagnost...ummary ,, GlobalData,s "Global In Vitro Diagno...

(Date:12/1/2009)...SHINGTON, Dec. 1 The Ke...inic in Los Angeles, has agreed to pay the United ...ceived illegal kickbacks from HealthSouth Corporat...,, The settlement resolves allegations that Hea... of stock option grants, donations to the Kerlan J...

(Date:12/1/2009)...eta is increasingly common but more easily identif...althDay News) -- A magnetic resonance imaging tes...ing pregnancy complication called placenta accreta...en the placenta surrounding a fetus attaches too d...acenta can pull out parts of the uterine wall, rup...

[0] Annual Screening With Breast Ultrasound or MRI Could Benefit Some Women [0] Targeted breast ultrasound can reduce biopsies for women under 40 [1] Reportlinker Adds Global In Vitro Diagnostics Market Analysis and Forecasts to 2015 [0] Los Angeles' Kerlan Jobe Orthopaedic Clinic Pays $3 Million to Settle Kickback Allegations [0] Serious Pregnancy Complication Detected With MRI

...ali Pharma, an emerging pharmaceutical company spe...s of its pivotal phase III clinical trial positive...acia(R) in children suffering from Vernal Keratoco... form of chronic allergic conjunctivitis character...

...November 18th to 22nd, 2007, under the responsibil...opole(R) is organizing an advanced course on stem ...t exploring the latest advancements of research in...and organ stem cells and cloning. Stem cel...

... Diagnostics today announces that it has completed...ger agreement with BioVeris for approximately $600...he Diagnostics now owns the patents for Electroche...ences research, life science development, patient ...

...y 100 people have been bitten and injured by a jac...o anti-rabies vaccines in the government hospitals...days, the jackal has attacked and injured villager...e being treated at different hospitals in Gopalgan...

...an refugees plan to introduce organic farming in I...pilot organic village will be set up in each of th...India," said Ngodup Dorje, head of the agriculture...sion ranging from training programmes and exposure...

...report on drugs has officially declared Britain th... a Daily Mail report, over 900,000 Britons buy coc...as the biggest user in the continent. In addition,...so said that successful law and order campaigns to...

Other Medicine News:Health News:Novagali Pharma Presents Phase III Clinical Trial of Vekacia(R) for Vernal Keratoconjunctivitis 2 Health News:Novagali Pharma Presents Phase III Clinical Trial of Vekacia(R) for Vernal Keratoconjunctivitis 3

Novagali Pharma Presents Phase III Clinical Trial of Vekacia(R) for Vernal Keratoconjunctivitis Genopole(R) is Organizing an Advanced Course on Stem Cells and Their Therapeutic Applications Roche Completes Acquisition of BioVeris Non-availability of Anti-rabies Vaccines Put Jackal Bitten Patients in a Fix Tibetans to Introduce Organic Farming Britain is Now Europe's Cocaine Capital

(Date:12/1/2009)..., Dec. 1 The new position of Execu...ip Biotechnologies, Inc. has been taken up by Howa... more than 30 years of experience creating and man...stein will direct Microchip Biotechnologies, marke...vice operations as the company makes the transitio...

(Date:12/1/2009)...1 CCS Medical, Inc. a leading dire... announced that it has received approval from the ...aware (the "Court") for its bidding procedures in ... substantially all of its assets. ,, Pursuant t...oved bidding procedures for the sale of substantia...

(Date:12/1/2009)...swire-FirstCall/ -- CryoLife, Inc. ( CRY) , an im...ular tissue processing company, announced its init... expects total revenues for the full year of 2010 ...hich includes between $1.5 million and $2.5 millio...of Defense in connection with the development of B...

Breaking Medicine Technology:Howard Goldstein Joins Microchip Biotechnologies, Inc. as Executive Vice President 2 CCS Medical Wins Approval from Bankruptcy Court for Its Chapter 11 Asset Sale Bidding Procedures 2 CryoLife Provides Initial 2010 Financial Guidance 2 CryoLife Provides Initial 2010 Financial Guidance 3 CryoLife Provides Initial 2010 Financial Guidance 4 CryoLife Provides Initial 2010 Financial Guidance 5 Global sunscreen wont save corals 8863 1 Global sunscreen wont save corals 8863 2 Spinal Decompression Therapy Offers Hope for Back Pain 49093 1 Spinal Decompression Therapy Offers Hope for Back Pain 49093 2 Potential for noninvasive brain tumor treatment 49089 1 Potential for noninvasive brain tumor treatment 49089 2

[0] Howard Goldstein Joins Microchip Biotechnologies, Inc. as Executive Vice President [0] CCS Medical Wins Approval from Bankruptcy Court for Its Chapter 11 Asset Sale Bidding Procedures [0] CryoLife Provides Initial 2010 Financial Guidance

... Stress the Importance to Patients of Passing a ...y, RICHMOND, Va., July 22 Insmed Inc. (Nasdaq,CM...pharmaceuticals, today,announced that Geoffrey All...ssional briefing on Friday, July 25th, 2008 to dis...oval pathway for follow-on,biologics (FOB) and sha...

...dated by Columbia University Medical Center Based ...A Technology, The Test Differentiates Squamous F...C), Classifying Squamous-Cell Carcinoma of the Lun...icity of 90 Percent,This is the First CLIA Approve... as Biomarkers for Accurate Diagnosis of Lung ...

Other Medicine Technology:Insmed CEO to Present at Congressional Briefing on Follow-On Biologics 2 Insmed CEO to Present at Congressional Briefing on Follow-On Biologics 3 First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 2 First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 3 First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 4 First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 5

Insmed CEO to Present at Congressional Briefing on Follow-On Biologics First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval

...nsive hemodynamic monitoring and information manag...raphics, clinical hemodynamic data, hemodynamic wa... all flow seamlessly into one complete cardiac pat...Both images and information are accessible on a si...

EXXCEL™ Soft Vascular Graft

...um is intended for monitoring the accuracy and pre... It is for in vitro diagnostic use only. Provided ...rs up to ten days stability at 2 8°C once rec...e with the directions accompanying the assay proce...

AdvancedMD Medical Claims Billing

Medicine Products:

Horizon Cardiology Hemo Hemodynamic Monitoring System EXXCEL™ Soft Vascular Graft Data Trol™ Abnormal Control Serum AdvancedMD Medical Claims Billing

Doctors Join Patients to Protest at Health Care Freedom Tea Parties July 17; Thousands Join in Nation...( WASHINGTON July 16 -- W...),Health